
Keywords: لامپ 1; Brimonidine; Phospholipidosis; α2 adrenergic agonist; α2 adrenergic antagonist; Meibomian gland dysfunction; Dry eye disease; phosphoinositide 3-kinase-protein kinase B; AKT; bovine pituitary extract; BPE; cationic amphiphilic drug; CAD; adenosine 3,5-c